Jakafi 25 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FPQR5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,259
Award facts
- Contract value 100% obligated
- $24,258.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $24.26K firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order, valued at $24,258.60, is for JAKAFI 25 mg tablets (60-count units), a prescription medication used in the treatment of myelofibrosis and polycythemia vera. This award was issued without a set-aside designation and represents performance at the vendor's Park Ridge, Illinois location. The contract type indicates this is a delivery order issued under an existing vehicle rather than a standalone procurement.
This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The IDC establishes DMS Pharmaceutical Group as a critical supplier of pharmaceutical products to Department of Defense healthcare facilities worldwide, covering an extensive portfolio including branded and generic prescription drugs, biologics, and medical consumables. The SPE2DB vehicle enables the DLA to issue firm fixed-price delivery orders for specific pharmaceutical items supporting military health facility requirements on a as-needed basis, with individual orders like this one addressing particular medication needs across the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FPQR5?
SPE2DB25FPQR5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FPQR5 worth?
The government has obligated $24,259 on SPE2DB25FPQR5.
Is contract SPE2DB25FPQR5 an order under another contract?
Yes. SPE2DB25FPQR5 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQR5 competed?
The extent of competition for SPE2DB25FPQR5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award